Found 2 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Melanocortin receptor 4
(Homo sapiens (Human)) | BDBM323182
(N-[(S)-2-(3-hydroxy-3-o-tolylazetidin-1-yl)-1-(4-m...)Show SMILES COc1ccc(C[C@H](NC(=O)CCc2c[nH]cn2)C(=O)N2CC(O)(C2)c2ccccc2C)cc1 Show InChI InChI=1S/C26H30N4O4/c1-18-5-3-4-6-22(18)26(33)15-30(16-26)25(32)23(13-19-7-10-21(34-2)11-8-19)29-24(31)12-9-20-14-27-17-28-20/h3-8,10-11,14,17,23,33H,9,12-13,15-16H2,1-2H3,(H,27,28)(H,29,31)/t23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a |
GALDERMA RESEARCH & DEVELOPMENT
US Patent
| Assay Description
In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the... |
US Patent US9630949 (2017)
BindingDB Entry DOI: 10.7270/Q21Z46H9 |
More data for this
Ligand-Target Pair | |
Melanocyte-stimulating hormone receptor
(Homo sapiens (Human)) | BDBM323182
(N-[(S)-2-(3-hydroxy-3-o-tolylazetidin-1-yl)-1-(4-m...)Show SMILES COc1ccc(C[C@H](NC(=O)CCc2c[nH]cn2)C(=O)N2CC(O)(C2)c2ccccc2C)cc1 Show InChI InChI=1S/C26H30N4O4/c1-18-5-3-4-6-22(18)26(33)15-30(16-26)25(32)23(13-19-7-10-21(34-2)11-8-19)29-24(31)12-9-20-14-27-17-28-20/h3-8,10-11,14,17,23,33H,9,12-13,15-16H2,1-2H3,(H,27,28)(H,29,31)/t23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a |
GALDERMA RESEARCH & DEVELOPMENT
US Patent
| Assay Description
In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the... |
US Patent US9630949 (2017)
BindingDB Entry DOI: 10.7270/Q21Z46H9 |
More data for this
Ligand-Target Pair | |